The other recent, major arrival is orforglipron (Foundayo), a small-molecule oral GLP-1 from Eli Lilly that the FDA approved for chronic weight management in April 2026
Potential Research Applications of Retatrutide Retatrutide is currently being explored in several research areas, including: Weight Management Research Scientists are studying whether multi-receptor agonists like Retatrutide can influence appetite pathways, caloric intake, and long-term weight regulation
Managing Semaglutide Expectations and Experiences What Patients Can Expect On a Semaglutide Starting semaglutide is a journey toward better health, but its important for patients to have realistic expectations
Citrus aurantium, which contains various compounds, including synephrine alkaloids, has been suggested as a safe alternative
Majors A, Ehrhart LA, and Pezacka EH (1997)